BCL2L1 and Thrombocytopenia: One consideration in using ABT263 is its mechanism of action, which involves the inhibition of antiapoptotic proteins like Bcl‐xL and Bcl‐2, known to induce platelet apoptosis and lead to thrombocytopenia.47